Search

Your search keyword '"Gotlib, Jason R."' showing total 7 results
Start Over Author "Gotlib, Jason R." Journal journal of clinical oncology
7 results on '"Gotlib, Jason R."'

1. Phase 3 trial of momelotinib (MMB) vs ruxolitinib (RUX) in JAK inhibitor (JAKi) naive patients with myelofibrosis (MF).

Author

Mesa, Ruben A., primary, Kiladjian, Jean-Jacques, additional, Catalano, John V., additional, Devos, Timothy, additional, Egyed, Miklos, additional, Hellman, Andrzei, additional, McLornan, Donal, additional, Shimoda, Kazuya, additional, Winton, Elliott F., additional, Deng, Wei, additional, Dubowy, Ronald L., additional, Maltzman, Julia D., additional, Cervantes, Francisco, additional, and Gotlib, Jason R., additional

Published
2017
Full Text
View/download PDF

2. The telomerase inhibitor imetelstat in patients (pts) with intermediate-2 or high-risk myelofibrosis (MF) previously treated with Janus kinase (JAK) inhibitor: A phase 2, randomized study.

Author

Tefferi, Ayalew, primary, Gangat, Naseema, additional, Niederwieser, Dietger, additional, Van Droogenbroeck, Jan, additional, Baer, Maria R., additional, Kiladjian, Jean-Jacques, additional, Hoffman, Ronald, additional, Finazzi, Guido, additional, Cervantes, Francisco, additional, Gotlib, Jason R., additional, Sirhan, Shireen, additional, Apperley, Jane, additional, Langlois, Angélique, additional, Wan, Ying, additional, Sherman, Laurie Jill, additional, Dougherty, Souria, additional, Feller, Faye, additional, and Odenike, Olatoyosi, additional

Published
2016
Full Text
View/download PDF

3. Phase 1/2 study of the activin receptor-like kinase (ALK)-2 inhibitor zilurgisertib (INCB000928, LIMBER-104) as monotherapy or with ruxolitinib (RUX) in patients (pts) with anemia due to myelofibrosis (MF).

Author

Bose, Prithviraj, Mohan, Sanjay, Oh, Stephen, Gotlib, Jason R., Ritchie, Ellen K., Shimomura, Taizo, Ali, Haris, Boyer, Francoise, Guglielmelli, Paola, Hunter, Anthony, Lamothe, Betty, Cui, Yi, Seguy, Francis, McBride, Amanda, Palandri, Francesca, Takeuchi, Masahiro, and Kiladjian, Jean-Jacques

Published
2023
Full Text
View/download PDF

4. Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis: Results from the ACE-536-MF-001 study.

Author

Gerds, Aaron Thomas, Harrison, Claire, Kiladjian, Jean-Jacques, Mesa, Ruben A., Vannucchi, Alessandro M., Komrokji, Rami S., Bose, Prithviraj, Kremyanskaya, Marina, Mead, Adam J., Gotlib, Jason R., Sanabria, Fabian, Marsousi, Niloufar, Giuseppi, Ana Carolina, Jiang, Huijing, Palmer, Jeanne M., McCaul, Kelly, Ribrag, Vincent, Verstovsek, Srdan, and Passamonti, Francesco

Published
2023
Full Text
View/download PDF

6. Phase 2 trial of PRM-151, an antifibrotic agent, in patients with myelofibrosis: Stage 1 results.

Author

Verstovsek, Srdan, primary, Mesa, Ruben A., additional, Foltz, Lynda M., additional, Gupta, Vikas, additional, Mascarenhas, John, additional, Ritchie, Ellen K., additional, Hoffman, Ronald, additional, Silver, Richard T., additional, Hong, Wan-Jen, additional, Kremyanskaya, Marina, additional, Trehu, Elizabeth G., additional, Kantarjian, Hagop M., additional, and Gotlib, Jason R., additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results